Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition.
Huynh MV, Parsonage D, Forshaw TE, Chirasani VR, Hobbs GA, Wu H, Lee J, Furdui CM, Poole LB, Campbell SL. Oncogenic KRAS G12C: Kinetic and redox characterization of covalent inhibition. J Biol Chem. 2022 Aug; 298(8):102186.